HMGB1 ELISA Kit (High Mobility Group Box 1) ELISA Kit
- Target See all HMGB1 ELISA Kits
- Detection Method
- Method Type
- Sandwich ELISA
- Detection Range
- 62.5 pg/mL - 4000 pg/mL
- Minimum Detection Limit
- 62.5 pg/mL
The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of HMG1 in human serum, plasma.
We offer validation data (WB) for the kit components. So you can be sure to order a reliable ELISA kit product composed of high quality reagents.
- Sample Type
- Plasma, Serum
- Analytical Method
- This assay has high sensitivity and excellent specificity for detection of High Mobility Group Protein 1 (HMGB1)
- Cross-Reactivity (Details)
- No significant cross-reactivity or interference between High Mobility Group Protein 1 (HMG1) and analogues was observed.
- 28.3 pg/mL
- Pre-coated, ready to use 96-well strip plate, flat buttom
- Plate sealer for 96 wells
- Reference Standard
- Standard Diluent
- Detection Reagent A
- Detection Reagent B
- Assay Diluent A
- Assay Diluent B
- Reagent Diluent (if Detection Reagent is lyophilized)
- TMB Substrate
- Stop Solution
- Wash Buffer (30 x concentrate)
- Instruction manual
Information on standard material:
The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.
Information on reagents:
The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.
Information on antibodies:
The provided antibodies and their host vary in different kits.
- Sample Volume
- 100 μL
- Assay Time
- 3 h
- Prepare all reagents, samples and standards,
- Add 100μL standard or sample to each well. Incubate 1 hours at 37 °C,
- Aspirate and add 100μL prepared Detection Reagent A. Incubate 1 hour at 37 °C,
- Aspirate and wash 3 times,
- Add 100μL prepared Detection Reagent B. Incubate 30 minutes at 37 °C,
- Aspirate and wash 5 times,
- Add 90μL Substrate Solution. Incubate 10-20 minutes at 37 °C,
- Add 50μL Stop Solution. Read at 450nm immediately.
- Reagent Preparation
- Bring all kit components and samples to room temperature (18-25 °C) before use. If the kit will not be used up in one time, please only take out strips and reagents for present experiment, and leave the remaining strips and reagents in required condition.
- Standard - Reconstitute the Standard with 0.5 mL of Standard Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). The concentration of the standard in the stock solution is 4,000pg/mL. Prepare 7 tubes containing 0.25 mL Standard Diluent and produce a double dilution series. Mix each tube thoroughly before the next transfer. Set up 7 points of diluted standard such as 4,000pg/mL, 2,000pg/mL, 1,000pg/mL, 500pg/mL, 250pg/mL, 125pg/mL, 62.5pg/mL, and the last microcentrifuge tube with Standard Diluent is the blank as 0pg/mL.
- Detection Reagent A and Detection Reagent B - If lyophilized reconstitute the Detection Reagent A with 150μL of Reagent Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). Briefly spin or centrifuge the stock Detection A and Detection B before use. Dilute them to the working concentration 100-fold with Assay Diluent A and B, respectively.
- Wash Solution - Dilute 20 mL of Wash Solution concentrate (30x) with 580 mL of deionized or distilled water to prepare 600 mL of Wash Solution (1x).
- TMB substrate - Aspirate the needed dosage of the solution with sterilized tips and do not dump the residual solution into the vial again.
- Making serial dilution in the wells directly is not permitted.
- Prepare standards within 15 minutes before assay. Please do not dissolve the reagents at 37 °C directly.
- Please carefully reconstitute Standards or working Detection Reagent A and B according to the instruction, and avoid foaming and mix gently until the crystals are completely dissolved. To minimize imprecision caused by pipetting, use small volumes and ensure that pipettors are calibrated. It is recommended to suck more than 10μL for one pipetting.
- The reconstituted Standards, Detection Reagent A and Detection Reagent B can be used only once.
- If crystals have formed in the Wash Solution concentrate (30x), warm to room temperature and mix gently until the crystals are completely dissolved.
- Contaminated water or container for reagent preparation will influence the detection result.
- Sample Preparation
- It is recommended to use fresh samples without long storage, otherwise protein degradation and denaturationmay occur in these samples, leading to false results. Samples should therefore be stored for a short periodat 2 - 8 °C or aliquoted at -20 °C (≤1 month) or -80 °C (≤ 3 months). Repeated freeze-thawcycles should be avoided. Prior to assay, the frozen samples should be slowly thawed and centrifuged toremove precipitates.
- If the sample type is not specified in the instructions, a preliminary test is necessary to determinecompatibility with the kit.
- If a lysis buffer is used to prepare tissue homogenates or cell culture supernatant, there is a possibilityof causing a deviation due to the introduced chemical substance.The recommended dilution factor is for reference only.
- Please estimate the concentration of the samples before performing the test. If the values are not in therange of the standard curve, the optimal sample dilution for the particular experiment has to be determined.Samples should then be diluted with PBS (pH =7.0-7.2).
- Assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level of target were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level of target were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV < 10%
Inter-Assay: CV < 12%
- For Research Use only
- Precaution of Use
- The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.
- 4 °C/-20 °C
- Storage Comment
- For unopened kit: All reagents should be stored according to the labels on the vials. The Standard, Detection Reagent A, Detection Reagent B, and 96-well Strip Plate should be stored at -20 °C upon receipt, while the other reagents should be stored at 4 °C.
- For opened kits: the remaining reagents must be stored according to the above storage conditions. In addition, please return the unused wells to the foil pouch containing the desiccant and seal the foil pouch with the zipper.
- Expiry Date
- 6 months
COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients." in: , Vol. 14, Issue 3, (2022) (PubMed).
: "Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease." in: Advances in experimental medicine and biology, Vol. 1113, pp. 27-35, (2019) (PubMed).
: "Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium." in: Stem cell reviews, Vol. 13, Issue 6, pp. 801-816, (2018) (PubMed).
: "Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 24, Issue 3, pp. 708-723, (2018) (PubMed).
: "PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy." in: Molecular cancer, Vol. 16, Issue 1, pp. 91, (2018) (PubMed).
: "Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells ..." in: BMC complementary and alternative medicine, Vol. 17, Issue 1, pp. 544, (2018) (PubMed).
: "Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment." in: Oncoimmunology, Vol. 7, Issue 3, pp. e1398874, (2018) (PubMed).
: "Increased serum levels of high mobility group protein B1 and calprotectin in pre-eclampsia." in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, Vol. 142, Issue 1, pp. 37-41, (2018) (PubMed).
: "Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer." in: Cancer immunology, immunotherapy : CII, Vol. 67, Issue 12, pp. 1897-1910, (2018) (PubMed).
: "Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians." in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, Vol. 39, Issue 6, pp. 1093-1104, (2018) (PubMed).
: "HMGB1-RAGE signaling pathway in pPROM." in: Taiwanese journal of obstetrics & gynecology, Vol. 57, Issue 2, pp. 211-216, (2018) (PubMed).
: "Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells." in: Immunologic research, Vol. 65, Issue 3, pp. 666-680, (2017) (PubMed).
: "SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from death." in: Biomedicine & pharmacotherapy, Vol. 88, pp. 449-458, (2017) (PubMed).
: "Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women." in: Biogerontology, Vol. 18, Issue 4, pp. 535-548, (2017) (PubMed).
: "Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases." in: Disease markers, Vol. 2017, pp. 5756102, (2017) (PubMed).
: "Oxidized low-density lipoprotein promotes osteoclast differentiation from CD68 positive mononuclear cells by regulating HMGB1 release." in: Biochemical and biophysical research communications, Vol. 495, Issue 1, pp. 1356-1362, (2017) (PubMed).
: "Serum levels of HMGB1 have a diagnostic role in metastatic renal cell cancer." in: Cancer biomarkers : section A of Disease markers, Vol. 17, Issue 1, pp. 17-20, (2016) (PubMed).
: "HMGB1 blockade differentially impacts pulmonary inflammation and defense responses in poly(I:C)/LPS-exposed heart transplant mice." in: Molecular immunology, Vol. 76, pp. 80-9, (2016) (PubMed).
: "Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines." in: Urolithiasis, Vol. 45, Issue 2, pp. 159-175, (2016) (PubMed).
: "The Role of High Mobility Group Box 1 Protein in Interleukin-18-Induced Myofibroblastic Transition of Valvular Interstitial Cells." in: Cardiology, Vol. 135, Issue 3, pp. 168-178, (2016) (PubMed).
- COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients." in: , Vol. 14, Issue 3, (2022) (PubMed).
- Target See all HMGB1 ELISA Kits
- Alternative Name
- High Mobility Group Protein 1 (HMGB1) (HMGB1 Products)
- HMG1, HMG3, SBP-1, DEF, HMG-1, Hmg1, amphoterin, p30, hmgb1, ik:tdsubc_1a5, wu:fb23c02, xx:tdsubc_1a5, zgc:56110, zgc:77104, hmg-1, hmg3, sbp-1, hmg1, HMGB1, Ac2-008, high mobility group box 1, high-mobility group box 1, high mobility group box 1a, high mobility group box 1 L homeolog, high mobility group protein B1, HMGB1, Hmgb1, hmgb1, hmgb1a, hmgb1.L, LOC100359149
- p53 Signaling, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Toll-Like Receptors Cascades, Smooth Muscle Cell Migration, Inflammasome